Ferring Pharmaceuticals Inc. et al v. Hetero USA Inc. et al
| Ferring Pharmaceuticals Inc. and Ferring International Center S.A. |
| Hetero USA Inc., Hetero Labs Limited and Hetero Labs Limited Unit-V |
| 1:2019cv00634 |
| April 4, 2019 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 11, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 14 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,450,338; US 8,481,083. (Attachments: #1 Voluntary Dismissal)(nms) |
Filing 13
ORAL ORDER: The proposed redacted filing at D.I. #12 is APPROVED. Ordered by Judge Richard G. Andrews on 7/11/2019. (nms)
|
| Filing 12 Letter to The Honorable Richard G. Andrews, from Daniel M. Attaway, regarding response to the Court's July 9, 2019 oral order (D.I. 11 ). (Attachments: #1 Exhibit)(Attaway, Daniel) Modified on 7/11/2019 (nms). |
| CORRECTING ENTRY: The pdf for D.I. 10 has been replaced with an amended version (see D.I. #12 , 13 ). The NEF for the filing has been regenerated. (nms) |
| CASE CLOSED per D.I. #9 . (nms) |
|
Filing 11
ORAL ORDER: The parties are directed to explain by the COB on July 15, 2019, why the Court should not unseal the joint stipulation (D.I. #9 ) in all aspects other than the specific date twice recited in the redacted filing. (D.I. #10 ).. Ordered by Judge Richard G. Andrews on 7/9/2019. (nms)
|
| Filing 10 REDACTED VERSION of #9 Stipulation of Dismissal by Ferring International Center S.A., Ferring Pharmaceuticals Inc.. (Bourke, Mary) (Main Document 10 replaced on 7/11/2019) (nms). |
| Filing 9 [SEALED] STIPULATION of Dismissal by Ferring International Center S.A., Ferring Pharmaceuticals Inc.. (Bourke, Mary) |
|
SO ORDERED, re #8 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Complaint to July 8, 2019. Signed by Judge Richard G. Andrews on 5/17/2019. (nms)
|
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 8 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Complaint to July 8, 2019 - filed by Ferring International Center S.A., Ferring Pharmaceuticals Inc.. (Bourke, Mary) |
| Filing 7 WAIVER OF SERVICE returned executed by Ferring Pharmaceuticals Inc., Ferring International Center S.A.: For Hetero Labs Limited waiver sent on 4/8/2019, answer due 7/8/2019; Hetero Labs Limited Unit-V waiver sent on 4/8/2019, answer due 7/8/2019. (Bourke, Mary) |
| Filing 6 SUMMONS Returned Executed by Ferring Pharmaceuticals Inc., Ferring International Center S.A.. Hetero USA Inc. served on 4/5/2019, answer due 4/26/2019. (Bourke, Mary) |
| Summons Issued with Magistrate Consent Notice attached as to Hetero USA Inc. on 4/5/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ferring Holding S.A. for Ferring International Center S.A.; Corporate Parent Ferring Holding Inc. for Ferring Pharmaceuticals Inc. filed by Ferring International Center S.A., Ferring Pharmaceuticals Inc. (ceg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,450,338; US 8,481,083. (ceg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/19/2019. Date of Expiration of Patent: 10/10/2028.Thirty Month Stay Deadline: 8/19/2021. (ceg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2611273.) - filed by Ferring Pharmaceuticals Inc., Ferring International Center S.A. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Civil Cover Sheet)(ceg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
